Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients.

BACKGROUND: Reactions are commonly associated with the chemotherapy of onchocerciasis. However unmanageable reactions are uncommon when ivermectin (Mectizan(®)) is used for the treatment of this infection, and this drug has proved to be a great improvement over previously used agents. Serious advers...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackenzie, Charles D, Geary, Timothy G, Gerlach, John A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147659/
https://www.ncbi.nlm.nih.gov/pubmed/14975062
http://dx.doi.org/10.1186/1475-2883-2-S1-S5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2147659/
https://www.ncbi.nlm.nih.gov/pubmed/14975062
http://dx.doi.org/10.1186/1475-2883-2-S1-S5

Ejemplares similares